Thursday, May 15, 2025
Home 2023

Yearly Archives: 2023

Psychedelic News

Psycheceutical’s (BWVI) NeuroDirect™ Ketamine can Help Alleviate Headaches and Migraines Within...

Editor / Curator -
2023 Watch List

Psycheceutical Bioscience (BWVI) Secures Funding for Clinical Trials

Editor / Curator -
2023 Watch List

Hepion Pharma (HEPA). Artificial Intelligence (AI) to Speed Drug Development.

Editor / Curator -
Client

Acquisition of Certain Minerva-Rockdale Oil and Gas Leases and Field Equipment...

Editor / Curator -
Client

Principal Solar Comments on SEC Action

Editor / Curator -
Pressure Bioscience, Biotech Stock Review, Roland Rick Perry
2023 Watch List

Pressure Bioscience (PBIO) Meets Ohio State University. Pressure Testing on Food...

Editor / Curator -
2023 Watch List

Adding Pressure BioSciences (PBIO) $0.80 to Watch List.

Editor / Curator -
2023 Watch List

CEO Interview: Ric Schumacher Pressure Bioscience (PBIO).

Editor / Curator -
pRESSURE bIOSCIENCE
2023 Watch List

Pressure BioSciences (PBIO) Receives $1.5M Contract for UltraShear Nanoemulsified CBD.

Editor / Curator -
2022 Watch List

Asia-Pacific: A Region of Stability Amidst Economic Uncertainty

Editor / Curator -
1...101112...18Page 11 of 18

Latest article

Nice Bounce on Alkaline Water (WTER) up 81%.

All News Editor / Curator -
Well now that ain't bad, up 81%! Our outlook on The Alkaline Water Company,...

Zomedica Corp (ZOMDF) $0.05

Uncategorized Editor / Curator -
Company Overview Background Zomedica Corp., incorporated in 2013 under the Business Corporations Act (Alberta), is...

Gold prices plunge in biggest one-day drop in years. Is the record rally over?...

All News Editor / Curator -
Easing anxieties over Trump’s tariff policies and the Fed chair’s fate spark gold’s worst daily decline since 2021 Gold...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.